mplantable cardioverter defibrillator (ICD) is widely used as an effective prevention of sudden cardiac death from ventricular fibrillation. The defibrillation threshold (DFT), which influences the safety and the efficacy of ICD, is reportedly increased by transient myocardial ischemia 1 and time-dependently after the onset of ventricular fibrillation. 2 DFT is usually estimated by electrical induction of ventricular fibrillation lasting several seconds under nonischemic conditions, and dynamic alteration of DFT in response to transient ischemia is not taken into account in the programming of the ICD.
Background
The defibrillation threshold (DFT) is elevated during myocardial ischemia, but the underlying mechanism remains to be elucidated. The hypothesis tested by the present study was that whole heart conductance (WHC) is a determinant of DFT. Methods and Results WHC was monitored across the longest diameter of the isolated perfused rat heart, using a 2-electrode instrument under various conditions including ischemia -reperfusion (IR). In the control study, WHC was influenced by the conductivity and flow rate of the solution. In IR, WHC decreased immediately after the onset of perfusion arrest in a single exponential manner, then declined again gradually. The second decrease was augmented and accelerated by pretreatment with 1.0 mmol/L heptanol (p<0.005) or high-[Ca 2+ ]e (p<0.001), and was attenuated and delayed by pretreatment with 1.0 mol/L verapamil (p<0.01). WHC after reperfusion was greater than the pre ischemic level. The postischemic increase in WHC was proportional to the ischemic interval and tissue water content as assessed by desiccation method. Conclusion Although time-dependent alterations in DFT in ischemic hearts may be attributable at least in part to dynamic changes in WHC, WHC should be interpreted carefully because it reflects many physiological factors such as coronary perfusion, electrical coupling of cardiac myocytes and tissue edema. 
I
with a volume-regulated peristaltic pump (model 7553-20, Cole Parmer, Chicago, IL, USA) was carefully controlled to maintain a constant flow rate (10 ml·min -1 ·g ww -1 ) to yield a physiological perfusion pressure (≈100 mmHg) during the equilibration period. 3 K-H solution was of the following composition: NaCl, 140.0; KCl, 5.4; CaCl2, 1.8; MgCl2, 0.5; NaH2PO4, 0.33; glucose, 5.5 (mmol/L). The external sodium concentration ([Na + ]e) was reduced or depleted depending on the experimental protocol by replacing NaCl with equimolar N-methyl-D-glucamine (Sigma, St Louis, MO, USA). Similarly, the external calcium concentration ([Ca 2+ ]e) was increased to 3.6 mmol/L, by substituting NaCl by CaCl2 to keep the total ionic strength of the solution constant. The solution was oxygenated with 100% O2 and the temperature was maintained at 37±1°C. The pH was adjusted to 7.4 using 10.0 mmol/L N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES; Sigma) with NaOH titration. Partial oxygen pressure of the solutions was estimated by a blood gas analyzer (ABL 620; Radiometer, Copenhagen, Denmark) and was approximately 850 mmHg. Osmotic pressure was estimated by a vapor pressure osmometer (Model 5520, Wescor Co Ltd, Logan, UT, USA) and was 290±4 mOsm/L. Effluent temperature estimated by thermister was 36±1°C.
WHC was evaluated by a commercially available DC conductance meter (M & S Instruments Inc, CD-35MII, Tokyo, Japan), which was calibrated using known resistors in the range of 10 S to 100 mS and connected to a pair of Ag-AgCl clip electrodes. Preliminary conductance measurement of solutions with differing [Na + ]e confirmed that this device was capable of real-time measurement of solution conductance, depending on [Na + ]e and interelectrode distance. A pair of clip electrodes was arranged on the surface of the heart in such a way that the interelectrode distance corresponded to the longest diameter of the preparations. Care was taken to minimize possible errors from electrode polarization by Ag-AgCl treatment, and effluentinduced short-circuiting of the electrodes by PA drainage. WHC and perfusion pressure were monitored continuously by a pen-writing recticorder (Nihon-Kohden, Tokyo, Japan), and stored on digital audiotapes using a data recorder (RD-101T PCM, TEAC, Tokyo) for off-line analyses (Fig 1A) . After each preparation was subjected to equilibration, perfusion protocols were commenced. Preparations showing sustained arrhythmias were excluded from data analyses (n=6).
Perfusion Protocols
A control perfusion study without any interventions (n= 4) was continued for 4 h because long-term Langendorff perfusion without erythrocytes and albumin is prone to cause tissue edema. 5, 6 As a test perfusion study, isolated hearts (n=50) were randomly assigned to one of 4 protocols. The first protocol was designed to assess the effects of heart rate on perfusion pressure and WHC (n=5). Preparations were paced at the desired rate by a pair of platinum clip electrodes attached to right atrial (RA) appendage and upper end of the RA free wall. After determining the RA pacing threshold, fixed rate pacing was conducted with 2 ms duration and twice the diastolic threshold intensity. RA pacing was undertaken over a wide range of pacing rate with 25 beats/min increments, depending on the initial spontaneous beating rate (275-400 beats/min). Then the effects of flow rate on perfusion pressure and WHC were investigated (n=5). The flow rate was altered carefully by regulating the peristaltic pump (3.0-13.0 ml·min -1 ·g ww -1 ), after which [Na + ]e was altered to assess the effects of solution conductance on perfusion pressure and WHC (n=5) (ie, [Na + ]e was gradually reduced, depleted and then normalized to 140 mmol/L). The flow rate was altered in some preparations under the [Na + ]e alteration (n=3). Finally, an IR insult was introduced by ceasing the Langendorff perfusion for an appropriate period (20, 40 or 60 min) and then restoring the perfusion to exactly the preischemic flow rate (n=7). Hearts were either untreated (control, n=7) or pretreated for 10 min before the 60 min insult with either high-[Ca 2+ ]e (3.6 mmol/L; n=7), verapamil (Sigma, 1.0 mol/L; n=7) or heptanol (Wako Chemical Co Ltd, Tokyo, Japan, 1.0 mmol/L; n=7). The second to fourth protocols were conducted without RA pacing.
Estimation of Tissue Water Content
Tissue water content was estimated by a desiccation technique (ie, all preparations weighed immediately after the perfusion study were placed in an oven to evaporate tissue water over a 48 h period under a constant temperature of 80°C). Relative tissue water content was calculated:
where WW is the wet weight at the end of perfusion study, and DW is the dry weight after desiccation. 3, 7 
Data Analysis
Data are presented as mean ± SD. Comparisons of vari- ous parameters among the different perfusion protocols were done by unpaired Student's t-test. Linear regression analysis was performed with the least-square method. Practical computation was done by commercially available statistical software (Microsoft Excel 2003, Microsoft, Tokyo, Japan). Results were considered to be statistically significant at p<0.05.
Results
Initial WHC values ranged from 2.1 to 3.0 (2.58±0.22) mS in the control perfusion study (n=4) and the 4 perfusion protocols (n=50). In the control perfusion at a flow rate of 10 ml·min -1 ·g ww -1 , neither WHC nor perfusion pressure showed significant alterations for 4 h. LVEDP at the end of control perfusion was 7.3±0.8 mmHg and the relative tissue water content was 54.8±4.7%, which was close to our previous perfusion study using isolated guinea pig hearts (51.1±2.9%). 3 This observation indicated that there was not any time-dependent deterioration of the preparations with 4 h of perfusion.
Effects of RA Pacing
All excised hearts (n=5) were captured by fixed RA pacing at rates up to 400 beats/min. As shown in Fig 2A, perfusion pressure and WHC remained unchanged during spontaneous beating and fixed RA pacing at 300 or 350 beats/min. The other 4 preparations also showed constant perfusion pressure and stable WHC under RA pacing ranging from 275 to 400 beats/min in the well perfusion (10 ml·min -1 ·g ww -1 ). 
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Effects of Flow Rate
As in Fig 2B, both the perfusion pressure and WHC changed in response to the stepwise alteration of the flow rate (3.0-12.5 ml·min -1 ·g ww -1 ). Fig 2C shows the changes in perfusion pressure and WHC as a function of flow rate. The steady state relationship between the perfusion pressure and flow rate in these preparations (n=5) was linear (r=0.979, p<0.005), and the slope theoretically indicates the total coronary resistance of the preparation. Steadystate WHC showed a small increase as the flow rate increased (r=0.997, p<0.001). Fig 3 shows representative data from the experiments investigating the effects of [Na + ]e reduction, depletion and normalization on the perfusion pressure and WHC under a constant flow rate of 10 ml·min -1 ·g ww -1 . The perfusion pressure gradually increased from 100 to 140 mmHg as [Na + ]e was reduced from 140 to 40 mmol/L. The perfusion pressure increased further to 180 mmHg with [Na + ]e depletion. As [Na + ]e was normalized, the perfusion pressure decreased to approximately 120 mmHg, but did not return completely to the baseline value. WHC was lowered by [Na + ]e reduction and restored by [Na + ]e normalization with a time lag for equilibration. Calibration was inserted at each step of [Na + ]e alteration by disconnecting and shortcircuiting the electrodes (arrows). Fig 4A summarizes the results from the 5 preparations subjected to this protocol, which indicate that WHC is strongly dependent on [Na + ]e. In 3 of 5 preparations, the flow rate gradually altered (from 3.0 to 13.0 ml·min -1 ·g ww -1 ) for each step of [Na + ]e reduction. As shown in Fig 4B, a linear 
Effects of [Na + ]e Reduction
Effects of IR
Global no-flow ischemia was achieved by abruptly ceasing perfusion while monitoring the perfusion pressure and WHC. At the beginning of ischemia of 20, 40 or 60 min in duration (n=7), the perfusion pressure decreased abruptly toward zero in a stepwise manner, but the reduction of WHC was delayed (Fig 5A) , corresponding to a semilogarithmic regression. The time constant ( ) of WHC decay was 108 s in this preparation (Fig 5B) , and for the other preparations ranged from 91 to 119 s (104±8 s). WHC monitoring during 60 min of no-flow ischemia is shown in Fig 6. Control ischemia caused an initial sharp reduction in WHC, which was followed by a quasi-steady state at approximately 0.9 mS for the first 20 min. Thereafter, WHC showed a further gradual decline for approximately 25 min after the onset of ischemia, and reached a final value of 0.4 mS. Pretreatment with verapamil (1.0 mol/L) had no influence on the initial decay, but attenuated the magnitude of the second gradual decline (ie, the difference between the quasi-steady state (0.9 mS) and minimum WHC (0.6 mS) was less than for the control ischemia). Moreover, verapamil delayed the onset of the second gradual decline (35 min after the onset of ischemia). In contrast, pretreatment with heptanol (1.0 mmol/L) augmented the magnitude of the second WHC decline (from 1.5 to 0.4 mS) and accelerated its onset (<20 min from the onset of ischemia) without any changes in the initial WHC decay. Pretreatment with high-[Ca 2+ ]e (3.6 mmol/L) caused similar changes in WHC to those observed with heptanol (data not shown). Table 1 summarizes the effects of the pretreatments with verapamil, heptanol and high- [Ca 2+ ]e on the dynamic changes of WHC in response to IR (ie, of the initial decay, relative magnitude and onset of the second gradual decline, and the minimum WHC). These pretreatments had no significant influence on the preischemic value of WHC and of its initial decay. The relative magnitude of the second decline (%) is expressed as the difference between the quasi-steady state and minimum WHC relative to that between the preischemic and minimum WHC values. This magnitude was significantly greater with the heptanol (n=7) and high-[Ca 2+ ]e (n=7) pretreatments (p<0.001) and less with verapamil (n=7) pretreatment (p<0.005) compared with the control ischemia (n=7). The onset of the second decline was significantly delayed by verapamil (p<0.01) and accelerated by heptanol (p<0.005) and high-[Ca 2+ ]e (p<0.001) pretreatments. The minimum WHC at the end of ischemia was significantly enhanced by verapamil (p<0.005), but significantly attenuated by high-[Ca 2+ ]e (p<0.05). Fig 7 shows the effects of reperfusion on the perfusion pressure and WHC at the preischemic flow rate (10 ml· min -1 ·g ww -1 ) (n=7). The duration of control ischemia was set at 20, 40 or 60 min. After the reperfusion, the perfusion pressure returned exactly to the preischemic level, but the WHC was greater than the preischemic level (Fig 7A) . The postischemic increase in WHC (%) was evident according to the lengthening of the ischemic interval (Fig 7B) . Moreover, this increase in WHC was proportional to the percent tissue water content (r=0.861, p<0.005) assessed by the desiccation technique (Fig 7C) . Postischemic increases in WHC were significantly enhanced by the high-[Ca 2+ ]e pretreatment (p<0.005) and lessened by the verapamil pretreatment (p<0.05), whereas heptanol pretreatment had no significant influence. LVEDP at the end of reperfusion in the verapamil group (7.9±0.2 mmHg) was significantly (p<0.001) reduced, whereas that in the high-[Ca 2+ ]e group (10.0±0.5 mmHg) was significantly (p<0.001) elevated relative to the control ischemia group (8.6±0.3 mmHg). The relative tissue water content in the verapamil group (59.1±1.3%) was lessened (p<0.001) and that in the high-[Ca 2+ ]e group (68.3±2.6%) was greater (p<0.005) than that in the control ischemia (63.4±2.0%). However, heptanol pretreatment showed no significant effects on either LVEDP or tissue water content (Table 1) .
Discussion
The main findings of this study are that (1) WHC in the well-perfused hearts decreases in response to a reduction of [Na + ]e, (2) WHC declines initially in a single exponential manner, and the subsequent quasi-steady state is followed by a second gradual decline during no-flow ischemia, (3) this gradual decline is augmented by both heptanol and high-[Ca 2+ ]e and attenuated by verapamil, and (4) the postischemic WHC is greater than the preischemic level and this difference is proportional to the ischemic interval and tissue water content.
WHC Under Physiological Perfusion
No prior studies have investigated the determinants of WHC comprehensively and in addition the interpretation of WHC is complicated because beating whole hearts contain inhomogeneous compartments (ie, vascular network containing solution, complex interstitial space and compact myocardium with variable extent of cellular coupling). In the present study the WHC remained constant under altered electrode positioning that kept the interelectrode distance to the longest preparation diameter, suggesting that epicardial fiber orientation and motion artifacts have no substantial impact on global WHC monitoring. Our perfusion study showed [Na + ]e-dependent coronary resistance (Figs 3,4) , which is in good agreement with the literature. 8 WHC in the well-perfused heart is also greatly influenced by [Na + ]e. This [Na + ]e-dependence is not only related to the altered solution conductivity, but is also ascribed to the [Na + ]e-dependent tissue excitability or cellular coupling mediated by the internal Ca 2+ concentration ([Ca 2+ ]i), which is regulated by the Na + /Ca 2+ exchanger. 9 Thus, WHC is considered to be governed by both coronary circulation and myocardial characteristics.
WHC During IR
As shown in Fig 1B, the gross equivalent circuit of our experiment is a parallel combination of (1) extracellular resistance (re) and (2) a series combination of intracellular resistance (ri) and membrane capacitance (Cm). 10 The contribution of coronary perfusion to cardiac impedance (or conductance as the inverse condition) depends greatly on the experimental setting and electrode design (ie, impedance rise during ischemia is controversial in large animal studies). [10] [11] [12] Kléber et al 13 used arterially perfused rabbit papillary muscle to evaluate re and ri and they reported an initial rise in re, which coincided with a fall in perfusion pressure at the onset of ischemia. In the present study, the WHC value halved within several minutes of control ischemia (Fig 6) . The single exponential decay of WHC in this phase was not influenced by any of the pretreatments ( Table 1 ), suggesting that vascular collapse (elevation of re) per se is involved (Fig 5) . Comparing our data with that from the literature, the relative contribution of re to tissue impedance in our study was greater than in other studies. [10] [11] [12] The second gradual decline of WHC is important because it relates to cellular uncoupling, which is one of the determinants of DFT. 14 The time course of this decline during control ischemia (Fig 6) was in good accordance with that of an increase in ri in papillary muscle subjected to ischemia. 13, 15 Myocardial ischemia induces intracellular acidosis, [Ca 2+ ]i overload, and a fall in ATP content, leading to cellular uncoupling. 16 Changes in the second WHC decline observed after the various pretreatments (Fig 6) 2+ ]i overload and delayed cellular uncoupling). 15 The preischemic WHC showed no significant changes with any of the pretreatments (Table 1 ) partly because of low re. The postischemic increase in WHC was proportional to the ischemic interval and tissue water content (Fig 7) and was modified by the various pretreatments (Table 1) , suggesting that postischemic WHC reflects tissue edema based on [Ca 2+ ]i-mediated IR injury. 17 Ischemic catabolite accumulation raises tissue osmolarity, and the transmembrane osmotic gradient causes time-dependent tissue swelling. [18] [19] [20] This is supported by significant (p<0.001) differences in LVEDP at the end of reperfusion in the verapamil and high-[Ca 2+ ]e groups relative to the control group in this study.
Clinical Implications
Our results suggest some clinical implications with respect to DFT. Coronary circulation collapses and [Ca 2+ ]i homeostasis is impaired by prolonged ventricular fibrillation. 21 In such circumstances, WHC declines (Figs 5,6 ), while DFT is reportedly elevated. 1,2 On the other hand, tissue edema increases WHC (Fig 7) and may elevate DFT. The effects of Ca antagonists on DFT are also controversial. 21, 22 Considering that DFT is influenced by many factors, such as [Ca 2+ ]e, 21 drugs, conduction velocity dispersion 23 and cellular coupling heterogeneity, 14 a comprehensive rule for predicting DFT requires further experimental and computational studies.
Study Limitations
First, WHC was not registered simultaneously with other electrophysiological parameters, such as epicardial ECG or local electrogram. This methodologic limitation prevented us from monitoring arrhythmias or correlating WHC with ECG parameters. Second, the electrode-tissue interface resistance (ro in Fig 1B) is not negligible in the 2-lead system. 11 Third, WHC is estimated by DC current traversing anisotropic resistive network of whole hearts. Frequencydependent myocardial impedance spectroscopy using AC current 10, 12 or nuclear magnetic resonance spectroscopy 17 may have been able to clarify the tissue characteristics in more detail, and to distinguish intracellular edema from interstitial edema.
Conclusion
DFT depends on the density of current traversing the whole heart at the moment of defibrillation. Although timedependent alterations in DFT in ischemic hearts may be attributable at least in part to dynamic changes in WHC, WHC data should be interpreted carefully because the monitoring reflects many physiological factors, such as coronary circulation, electrical coupling of contiguous cardiac myocytes, and myocardial tissue edema.
